Jun 28, 2017
Former Bristol-Myers Squibb scientist and regulatory affairs expert joins Recursion SALT LAKE CITY, June 28, 2017 / PRNewswire / --  Recursion Pharmaceuticals , an emerging biotechnology company today announced it has hired Dr. Chand Sishta as the senior director of regulatory affairs.
Displaying 61 - 70 of 71